CHAPTER 173
HB 1453 - FINAL VERSION
2016 SESSION
\t16-2469
\t01/04
HOUSE BILL\t1453
AN ACT\trelative to qualifying medical conditions for purposes of therapeutic cannabis.
SPONSORS:\tRep. Luneau, Merr. 10; Rep. Myler, Merr. 10; Rep. Wallner, Merr. 10; Sen. Feltes, Dist 15
COMMITTEE:\tHealth, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
\tThis bill adds ulcerative colitis to the list of qualifying medical conditions for purposes of therapeutic cannabis.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation:\tMatter added to current law appears in bold italics.
\t\tMatter removed from current law appears [in brackets and struckthrough.]
\t\tMatter which is either (a) all new or (b) repealed and reenacted appears in regular type.
\t16-2469
\t01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Sixteen
AN ACT\trelative to qualifying medical conditions for purposes of therapeutic cannabis.
Be it Enacted by the Senate and House of Representatives in General Court convened:
\t173:1 Use of Cannabis for Therapeutic Purposes; Definition. Amend RSA 126-X:1, IX(a)(1) to read as follows:
\t\t\t\t(1) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and
\t173:2 Effective Date. This act shall take effect 60 days after its passage.
Approved: June 3, 2016
Effective Date: August 2, 2016